glp 1 approved for obesity 175: Live! Small Doses, Big Changes: Updates in Medicine with GLP-1s The first ever FDA-approved GLP-1

Salidroside inhibits renal ischemia/reperfusion injury-induced ferroptosis by the PI3K/AKT signaling pathway

Gyimesi M, Okolicsanyi RK, Haupt LM (2024) Beyond amyloid and tau: rethinking Alzheimers disease through less explored avenues

The Bottom Line Success on GLP-1 medications isn't just about taking your weekly injectionit's about pairing that medication with a strategic nutrition approach that preserves muscle, minimizes side effects, and sets you up for long-term sustainable weight loss

Carcaterra and Caruso, 2021)

Comparative effectiveness of sodiumglucose cotransporter 2 inhibitors vs sulfonylureas in patients with type 2 diabetes